30
Participants
Start Date
February 28, 2007
Primary Completion Date
February 10, 2008
Study Completion Date
March 15, 2008
n-3 PUFA Group
Participants received n-3 PUFA capsules (capsules containing 180 mg of eicosapentaenoic acid, 120 mg of docosahexaenoic acid and 2 mg of vitamin E). Three capsules were ingested daily for eight weeks, distributed between breakfast, lunch and dinner.
Placebo Group
Participants received capsules containing 500 mg of gelatin.Three capsules were ingested daily for eight weeks, distributed between breakfast, lunch and dinner.
Clinical Hospital of Porto Alegre, Pôrto Alegre
Federal University of Rio Grande do Sul
OTHER